Literature DB >> 4001724

Delayed manifestations of congenital rubella.

J L Sever, M A South, K A Shaver.   

Abstract

The manifestations of congenital rubella syndrome (CRS) can be grouped according to time of onset into newborn, extended, and delayed CRS. The delayed manifestations are not present in early life and include the following: endocrinopathies: diabetes, thyroid disease, and growth hormone deficiency; deafness; ocular damage: glaucoma, keratic precipitates, keratoconus, corneal hydrops, and absorption of the cataractous lens; vascular effects: fibromuscular proliferation of the intima, sclerosis of arteries, systemic hypertension secondary to renal disease, and subretinal neovascularization; and progressive rubella panencephalitis. Several mechanisms of pathogenesis of the damage have to be considered for the delayed manifestations, including growth of the virus in tissues, resulting in a reduced growth rate and shortened life-span of the cells; autoimmune responses, initially stimulated by the infection; genetic susceptibility; vascular damage by the viral infection with further stenosis or occlusion of the vessels later; reactive hypervascularization; and chronic persistence of the virus in the tissue with subsequent extension of the infection to other areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001724     DOI: 10.1093/clinids/7.supplement_1.s164

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

Review 1.  Consequences of congenital Zika virus infection.

Authors:  Derek J Platt; Jonathan J Miner
Journal:  Curr Opin Virol       Date:  2017-11-06       Impact factor: 7.090

Review 2.  Congenital hearing loss.

Authors:  Anna M H Korver; Richard J H Smith; Guy Van Camp; Mark R Schleiss; Maria A K Bitner-Glindzicz; Lawrence R Lustig; Shin-Ichi Usami; An N Boudewyns
Journal:  Nat Rev Dis Primers       Date:  2017-01-12       Impact factor: 52.329

Review 3.  Public Health Approach to Addressing the Needs of Children Affected by Congenital Zika Syndrome.

Authors:  Cheryl S Broussard; Carrie K Shapiro-Mendoza; Georgina Peacock; Sonja A Rasmussen; Cara T Mai; Emily E Petersen; Romeo R Galang; Kimberly Newsome; Megan R Reynolds; Suzanne M Gilboa; Coleen A Boyle; Cynthia A Moore
Journal:  Pediatrics       Date:  2018-02       Impact factor: 7.124

4.  The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.

Authors:  J F O'Neill
Journal:  Trans Am Ophthalmol Soc       Date:  1998

5.  Evaluation of alternative endpoints for ZIKV vaccine efficacy trials.

Authors:  Rachel A Mercaldo; Steven E Bellan
Journal:  Vaccine       Date:  2019-03-11       Impact factor: 3.641

6.  Persistent intraocular rubella infection in a patient with Fuchs' uveitis and congenital rubella syndrome.

Authors:  Stephen A Winchester; Zsolt Varga; Dipak Parmar; Kevin E Brown
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

7.  Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.

Authors:  H Viskari; J Paronen; P Keskinen; S Simell; B Zawilinska; I Zgorniak-Nowosielska; S Korhonen; J Ilonen; O Simell; A-M Haapala; M Knip; H Hyöty
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

8.  Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders.

Authors:  K T Givens; D A Lee; T Jones; D M Ilstrup
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

9.  Autoimmune Thyroid Disease and Keratoconus: Is There an Association?

Authors:  Hussam H Alhawari; Yousef S Khader; Hussein H Alhawari; Amal F Alomari; Hiba N Abbasi; Muhannd S El-Faouri; Muawyah D Al Bdour
Journal:  Int J Endocrinol       Date:  2018-07-31       Impact factor: 3.257

Review 10.  A complex interaction between drug allergy and viral infection.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.